Catalogo dei prodotti della ricerca

DE SANTIS, Adriano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.593
EU - Europa 5.930
AS - Asia 1.366
SA - Sud America 128
AF - Africa 74
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.098
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.491
IT - Italia 4.296
SG - Singapore 730
IN - India 334
SE - Svezia 316
FI - Finlandia 219
UA - Ucraina 210
CN - Cina 203
DE - Germania 190
RU - Federazione Russa 158
GB - Regno Unito 107
FR - Francia 101
NL - Olanda 93
CA - Canada 79
BR - Brasile 76
IE - Irlanda 53
BG - Bulgaria 42
AR - Argentina 37
AT - Austria 32
BE - Belgio 28
CH - Svizzera 23
TG - Togo 21
ID - Indonesia 20
BJ - Benin 18
RO - Romania 15
ZA - Sudafrica 14
TR - Turchia 12
MX - Messico 11
PK - Pakistan 11
MY - Malesia 9
IR - Iran 8
BZ - Belize 7
HK - Hong Kong 7
PL - Polonia 7
PT - Portogallo 7
AL - Albania 6
EG - Egitto 6
CO - Colombia 5
ES - Italia 5
AU - Australia 4
KR - Corea 4
LT - Lituania 4
SA - Arabia Saudita 4
SC - Seychelles 4
VN - Vietnam 4
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
DZ - Algeria 3
EC - Ecuador 3
GR - Grecia 3
GT - Guatemala 3
KG - Kirghizistan 3
BD - Bangladesh 2
CI - Costa d'Avorio 2
CL - Cile 2
HR - Croazia 2
IQ - Iraq 2
JO - Giordania 2
JP - Giappone 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PY - Paraguay 2
RS - Serbia 2
SI - Slovenia 2
TW - Taiwan 2
AZ - Azerbaigian 1
BO - Bolivia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GH - Ghana 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
VE - Venezuela 1
Totale 14.098
Salva come PNG Salva come JPEG
Città #
Fairfield 1.079
Rome 698
Woodbridge 562
Chandler 496
Ashburn 452
Seattle 383
Houston 367
Singapore 357
Wilmington 356
Cambridge 328
Ann Arbor 258
Milan 255
Princeton 209
Plano 154
Dearborn 146
Santa Clara 126
San Paolo di Civitate 115
Naples 108
Florence 107
Palermo 103
Lawrence 93
Millbury 91
Beijing 88
Jacksonville 83
Turin 83
Helsinki 75
Boston 68
San Diego 67
Bologna 61
Andover 59
Cosenza 57
Catania 54
Dublin 52
Des Moines 49
Moscow 49
Ottawa 48
Fremont 47
Bari 45
Bremen 36
Federal 36
Sofia 35
Falkenstein 34
Pisa 34
New York 33
Norwalk 31
Perugia 30
Falls Church 29
Lucca 29
Brussels 28
Frankfurt am Main 28
Brescia 27
Genoa 27
Livorno 27
Boardman 25
San Jose 25
Toronto 24
Vienna 23
Padova 22
Lomé 21
Southend 21
Verona 20
Cagliari 19
Jakarta 19
London 19
Reggio Emilia 19
San Mateo 18
Dallas 17
Fasano 17
Bühl 15
Bergamo 14
Camden 14
Caserta 14
Cascina 12
Johannesburg 12
Los Angeles 12
Monza 12
Rimini 12
Yubileyny 12
Auburn Hills 11
Formigine 11
Kunming 11
Modena 11
Nanjing 11
Pescara 11
Salerno 11
Council Bluffs 10
Arezzo 9
Hefei 9
Mannheim 9
Parma 9
Ravenna 9
Altopascio 8
Empoli 8
Iesi 8
Lamezia Terme 8
Latina 8
São Paulo 8
Belize City 7
Grezzana 7
Kuala Lumpur 7
Totale 8.931
Salva come PNG Salva come JPEG
Nome #
Ridotta prevalenza di “skip areas” nel fegato steatosico in pazienti con calcolosi multipla della colecisti ed in soggetti colecistectomizzati 2.736
FISIOLOGIA DEL FEGATO E METABOLISMO ENERGETICO 1.195
Angiogenic factors as prognostic markers in neuroendocrine neoplasms 197
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study 125
Diagnostic imaging for hepatocellular carcinoma 114
Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hcv-related cirrhosis 109
Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: A pilot study 107
An isolate alpha-fetoprotein producing gastric cancer liver metastasis emerged in a patient previously affected by radiation induced liver disease 106
Is spontaneous bacterial peritonitis an inducer of vasopressin analogue side-effects? 106
Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: Description, prevalence and risk factors 105
Beneficial effect of sulphate-bicarbonate-calcium water on gallstone risk and weight control 102
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia 99
The human gut microbiota and virome: potential therapeutic implications 98
Reduced lysosomal acid lipase activity in blood and platelets is associated with nonalcoholic fatty liver disease 98
Progressive reduction of blood lysosomal acid lipase activity according to stage of adult chronic liver disease and altered enzymatic cellular distribution in cirrhosis 97
Application of acoustic radiation force impulse elastography in non invasive diagnosis of focal nodular hyperplasia 97
Intestinal Permeability In Non-Alcoholic Fatty Liver Disease: The Gut-Liver Axis. 96
The activation of IGF1 system is a requisite for cholangiocyte survival during the progression of primary biliary cirrhosis (PBC) 96
Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. 94
Abnormalities in erythrocyte membrane phospholipids in patients with liver cirrhosis 94
International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement 92
Nutritional habits in patients with chronic liver disease: adherence of real life diet to international guidelines and its association with disease stage 92
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement 91
A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption 90
Clinical course, management, and platelet activity assessment of splanchnic VITT: a case report 90
HAMP GENE MUTATION C.208T>C (P.C70R) IDENTIFIED IN AN ITALIAN PATIENT WITH SEVERE HEREDITARY HEMOCHROMATOSIS. 89
Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis 88
The modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt 88
ACOUSTIC RADIATION FORCE IMPULSE ELASTOGRAPHY" (ARFI) ASSESSMENT OF FOCAL NODULAR HYPERPLASIA: PRELIMINARY RESULTS 88
One month post-operative serum insulin predicts serum aminotransferase elevation and fibrosis progression due to HCV recurrence after liver transplantation 87
The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti-hepatitis C virus therapy. 87
A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption 87
Microbial translocation and T cell activation are modified by direct-acting antiviral therapy in HCV-infected patients 86
Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C 83
ONE MONTH POST-OPERATIVE SERUM INSULIN PREDICTS SERUM AMINOTRANSFERASE ELEVATION AND FIBROSIS PROGRESSION DUE TO HCV RECURRENCE AFTER LIVER TRANSPLANTATION 82
PREDICTIVE RISK FACTORS OF RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION 81
Management of refractory typical GERD symptoms 81
Bile acid metabolism in liver disease 80
Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection 80
Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging 80
Clinical Manifestations of gallstone disease: evidence from the Multicenter Italian study on Cholelithiasis (MICOL) 79
Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitis. 79
Polytetrafluoroethylene-covered stent grafts for TIPS procedure: 1-year patency and clinical results 79
Inherited coagulation disorders in cirrhotic patients with and without portal vein trhombosis (PVT) 78
Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies. 78
Hepatic steatosis after liver transplantation: Prevalence and associated factors 77
Probiotics for the hemodynamic alterations of patients with liver cirrhosis. 77
Ultrasonography in the study of hepatocellular carcinoma in woodchucks chronically infected with WHV 76
ARFI Elastometry Assessment of Focal Nodular Hyperplasia: Preliminary Results 75
Expression of estrogen receptors in cholangiocytes of patients with primary biliary cirrhosis (PBC) and relationship with immunohistochemical markers of cell proliferation and death 74
Epidemiology of gallstone disease in Italy: Prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.) 72
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis. A real-life study 72
Severe rectal prolapse and solitary rectal ulcer in a young anorectic woman with myxoid degeneration of visceral adipose tissue 72
Transjugular intrahepatic portosystemic shunt (TIPS) is feasible in non-cirrhotic patients with cavernomatous tranformation of the portal vein 71
Epidemiologia della colelitiasi in Italia . Esperienze del GREPCO: Gruppo Romano per l'Epidemiologia e la Prevenzione della Colelitiasi 71
IS SKIN TOXICITY A PREDICTOR OF BETTER SURVIVAL OF PATIENTS WITH HCC TREATED WITH SORAFENIB? 71
Biliary sludge: a critical update. 70
Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients 70
Diet and gallstones in Italy: The cross-sectional MICOL results 69
Prevalenced of portal vein thrombosis (PVT) and associated factors in cirrhotic patients 69
Correction to: Reduced lysosomal acid lipase activity in blood and platelets Is associated with nonalcoholic fatty liver disease 69
Kinetic characterisation in needle biopsies of hepatocellular carcinama: feasibility and preliminari results. 68
Prevalence of gallstone disease in an Italian adult female population. 68
Gallstones and diabetes: a case - control study in a free - living population sample. 68
PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis 68
Hepatocellular carcinoma in cirrhotic patients with transjugular intrahepatic portosystemic shunt: A retrospective case-control study 68
Clinical symptoms and gallstone disease: lessons from a population study 68
Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody 68
Biliary Secretion of Phosphatidylcholine and its molecular species in cholecystectomized T - Tube patients: Effects of bile acid hydrophilicity. 68
Increased energy expenditure in cirrhotic patients with hepatocellular carcinoma. 67
IS SKIN TOXICITY A PREDICTOR OF BETTER SURVIVAL OF PATIENTS WITH HCC TREATED WITH SORAFENIB? 66
Incidence and natural history of small esophageal varices in cirrhotic patients 65
Beta adrenergic receptors in the parathyroid glands. 65
Increased resting energy expenditure in patients with hepato cellular carcinoma 64
Sterile abscesses complicating monoclonal gammopathy of undetermined significance. 64
Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts 64
A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B. 63
Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee. 63
TREATMENT WITH INTERFERON (IFN) PLUS RIBAVIRIN (RBV) OF β-THALASSEMIC PATIENTS WITH HCV CHRONIC HEPATITIS 63
Is skin toxicity a predictor of better survival of patients with HCC treated with sorafenib? 63
The natural history of gallstones: the GREPCO experience 62
Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis 60
PRESENTATION OF THE RIFLE PROJECT RISK-FACTORS AND LIFE EXPECTANCY 60
null 60
Gallbladder ultrasonography as a diagnostic tool in epidemiological screenings 59
Cost analysis for the prevention of variceal rebleeding in cirrhotic patients: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy 59
Dermatologic lesions in patients with chronic hepatitis C treated with alfs interferon alone or in combination with ribavirin and with or without amantadine 58
Prevalence of gallstone disease in first-degree relatives of patients with cholelithiasis. 58
Effect of a medium dose of Ursodeoxycholic acid with or without Taurine supplementation on the nutritional status of patients with Cystic fibrosis:A randomized, placebo-controlled,crossover trial 57
Patterns of chronic hepatitis B in Central Italy: a cross-sectional study 57
Cholelithiasis and blood groups: evidence for a lack of association 56
The GREPCO research programmes: aims and prevalence data. 55
Etiology, management, and outcome of the Budd-Chiari syndrome. 55
THE DIABETES-CHOLELITHIASIS ASSOCIATION IN A CASE-CONTROL STUDY 55
Small hepatic veins Budd-Chiari syndrome and paroxysmal nocturnal hemoglobinuria - The association of two rare entities: a case report 55
Role of Octreoscan in advanced hepatocellular carcinoma 54
null 54
Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis 54
Factors associated with gallstone disease: observations in the GREPCO Study 53
Portal vein thrombosis (PVT) in cirrhotic patients: Prevalence and associated factors 53
Totale 11.526
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.595
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020541 0 0 0 0 0 0 0 0 235 151 87 68
2020/2021947 101 95 54 112 42 63 19 79 77 199 71 35
2021/20221.967 37 79 167 56 259 72 65 213 166 158 312 383
2022/20232.706 408 376 117 295 269 259 142 179 245 123 165 128
2023/20242.272 134 188 170 198 206 239 224 206 51 238 189 229
2024/20252.612 218 217 263 219 311 298 317 232 537 0 0 0
Totale 14.396